When combined with a checkpoint inhibitor (anti-PD-L1) and T-cell activators (anti-CD3 and anti-CD28), the iron oxide-based magnetic nanomaterial can repair the immunosuppressive tumor microenvironment (ITM) by reinvigorating tumor-infiltrating lymphocytes 95. The gene discussed is CD28; the disease is neoplasm.